2Xideas UCITS Glbl Mid Cap Lib S EUR H |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | 30.2 | 15.3 | -32.3 | 13.6 | -1.8 | |
+/-Cat | - | - | - | - | - | |
+/-Idx | - | - | - | - | - | |
Category: Other Equity | ||||||
Benchmarks: - |
Key Stats | ||
NAV 16/05/2024 | EUR 131.00 | |
Day Change | -0.10% | |
Morningstar Category™ | Other Equity | |
ISIN | LU2001262547 | |
Fund Size (Mil) 16/05/2024 | USD 582.86 | |
Share Class Size (Mil) 16/05/2024 | EUR 44.22 | |
Max Initial Charge | - | |
Ongoing Charge 31/03/2023 | 1.00% |
Investment Objective: 2Xideas UCITS Glbl Mid Cap Lib S EUR H |
The investment objective of the Fund is long-term capital growth. In order to achieve the investment objective, the Sub-Fund shall be invested in at least 70 equity securities. The investment universe comprises equity securities of mid and large cap companies listed on a regulated stock exchange. In general, these securities shall be issued by companies having a market capitalization of at least USD 2 billion (or an equivalent value in another currency). The investments may be worldwide and in any currency. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Michael Stutz 30/04/2018 | ||
Henrik Munk Nielsen 30/04/2018 | ||
Inception Date 30/08/2019 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for 2Xideas UCITS Glbl Mid Cap Lib S EUR H | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Kinsale Capital Group Inc | Financial Services | 1.83 |
Lonza Group Ltd | Healthcare | 1.67 |
Ryan Specialty Holdings Inc Class A | Financial Services | 1.51 |
Edwards Lifesciences Corp | Healthcare | 1.46 |
American Express Co | Financial Services | 1.42 |
Increase Decrease New since last portfolio | ||
2Xideas UCITS Glbl Mid Cap Lib S EUR H |